Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Androgen-dependent TFPI-regulating protein (ADTRP) is a membrane-associated enzyme encoded by the ADTRP gene (previously C6orf105) and is primarily expressed in endothelial cells. It is inducible by androgens and plays a critical role in regulating the expression and activity of tissue factor pathway inhibitor (TFPI), the major inhibitor of the tissue factor-dependent coagulation pathway. ADTRP also demonstrates hydrolase activity specific for fatty acid esters of hydroxy fatty acids (FAHFAs), contributing to anti-diabetic and anti-inflammatory lipid metabolism. Functionally, ADTRP supports vascular development and barrier integrity, in part by modulating Wnt signaling and matrix metalloproteinase-9 (MMP-9) expression. Genetic variants of ADTRP are associated with several vascular diseases, including coronary artery disease and thrombosis, and its deficiency can cause abnormal angiogenesis, vascular leakage, and increased inflammation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Androgen-dependent TFPI-regulating protein (ADTRP).